4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
SOL S.p.A. (SOL) operates in the Specialty Chemicals industry and is headquartered in Monza, Italy with about 8,000 employees. Its market capitalization is roughly €5 billion.
SOL S.p.A. produces and distributes technical and medical gases for industry and healthcare facilities in Italy and internationally.
Interactive charts & full statements → Open the SOL valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | — | €1.6B | €1.5B | €1.4B | €1.1B |
| Gross Profit | — | €1.2B | €1.1B | €898M | €828M |
| Operating Income (EBIT) | — | €208M | €190M | €109M | €125M |
| Net Income | — | €148M | €146M | €134M | €90M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2025-06-30 |
|---|---|---|
| Total Revenue | €488M | €448M |
| Gross Profit | €377M | €339M |
| Operating Income (EBIT) | €75M | €67M |
| Net Income | €42M | €41M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Dividends Paid | (€38M) | (€34M) | (€24M) | (€24M) |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Assets | €2.1B | €1.9B | €1.7B | €1.4B |
| Total Liabilities | €1.1B | €966M | €856M | €723M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SOL viewer.
About TickerBase · Data methodology & sources · Privacy · Terms